Cite
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018.
MLA
Finlay, David B., et al. “Exploring Determinants of Agonist Efficacy at the CB1 Cannabinoid Receptor: Analogues of the Synthetic Cannabinoid Receptor Agonist EG‐018.” Pharmacology Research & Perspectives, vol. 10, no. 2, Feb. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1002/prp2.901.
APA
Finlay, D. B., Nguyen, T., Gamage, T. F., Chen, S., Barrus, D. G., Patel, P. R., Thomas, B. F., Wiley, J. L., Zhang, Y., & Glass, M. (2022). Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018. Pharmacology Research & Perspectives, 10(2), 1–11. https://doi.org/10.1002/prp2.901
Chicago
Finlay, David B., Thuy Nguyen, Thomas F. Gamage, Shuli Chen, Daniel G. Barrus, Purvi R. Patel, Brian F. Thomas, Jenny L. Wiley, Yanan Zhang, and Michelle Glass. 2022. “Exploring Determinants of Agonist Efficacy at the CB1 Cannabinoid Receptor: Analogues of the Synthetic Cannabinoid Receptor Agonist EG‐018.” Pharmacology Research & Perspectives 10 (2): 1–11. doi:10.1002/prp2.901.